Thymosin β4 Gene Expression in Leukemic Cells

References

• Goldstein A. L., Slater F. D., White A. Preparation, assay and partial purification of a thymic lymphocytopoietic factor (thymosin). Proc. Natl. Acad. Sci. U.S.A 1966; 56: 1010–1017
   PubMed Web of Science ®Google Scholar
• Thurman G. B., Low T. L. K., Rossio J. L., Goldstein A. L. Specific and nonspecific macrophage migration inhibition. Lymphokines and Thymic Hormones: Their potential utilization in cancer therapeutics, A. L. Goldstein, M. A. Chirigos. Raven Press, New York 1981; 145–157
   Google Scholar
• Wolf R. E., Maca R. D. Suppressive effect of thymosin fraction 5 on proliferation of cultured human lymphocytes. Immunopharmacol 1986; 12: 223–240
   Web of Science ®Google Scholar
• Sztein M. B., Serrate S. A., Goldstein A. L. Modulation of interleukin 2 receptor expression on normal human lymphocytes by thymic hormones. Proc. Natl. Acad. Sci. U.S.A 1986; 83: 6107–6111
   PubMed Web of Science ®Google Scholar
• Serrate S. A., Schulof R. S., Leonadaridis L., Goldstein A. L., Sztein M. B. Modulation of human natural killer cell cytotoxic activity, lymphokine production, and interleukin 2 receptor expression by thymic hormones. J. Immunol 1987; 139: 2338–2343
   PubMed Web of Science ®Google Scholar
• Reddy M. M., Grieco M. H. In vitro immunomodulatory effects of interleukin-2 and thymosin fraction V in acquired immune deficiency syndrome. Int. J. Immunopharmac 1987; 9: 483–488
   PubMed Web of Science ®Google Scholar
• Kouttab N. M., Goldstein A. L., Lu M., Lu L., Campbell B., Maizel A. L. Production of human B and T cell growth factors is enhanced by thymic hormones. Immunopharmacol 1988; 16: 97–105
   PubMed Web of Science ®Google Scholar
• Skotnicki A. B., Zatz M., Sztein M. B., Goldstein A. L., Schulof R. S. Effect of thymic hormones on interleukin 2 synthesis by lymphocytes from HIV-positive pre-AIDS subjects. Immunol. Invest 1988; 17: 159–164
   PubMed Web of Science ®Google Scholar
• Hsia J., Sarin N., Oliver J. H., Goldstein A. L. Aspirin and thymosin increase interleukin-2 and interferon-γ production by human peripheral blood lymphocytes. Immunopharmacol 1989; 17: 167–173
   PubMed Web of Science ®Google Scholar
• Asakawa M., Kinoshita Y., Kimura S., Hato F., Wada S., Nishijima T., Kishimoto T., Maekawa M. Restorative effects of thymosin fraction 5 on reduction in responsiveness of rat thymocytes to allogenic lymphocytes during bladder tumor induction. Cell. Mol. Biol 1990; 36: 265–274
   PubMed Web of Science ®Google Scholar
• Rebar R. W., Miyake A., Low T. L. K., Goldstein A. L. Thymosin stimulates secretion of luteinizing hormone releasing factor. Science 1981; 214: 669–671
   PubMed Web of Science ®Google Scholar
• Healy D. L., Hodgen D., Schulte H. M., Chrousos G. P., Loriaux D. L., Hall N. R., Goldstein A. L. The thymus-adrenal connection: Thymosin has corticotropin releasing activity in primates. Science 1983; 222: 1353–1355
   PubMed Web of Science ®Google Scholar
• Rouabhia M., Ghanmi Z., Deschaux P. A. Interaction between luteotrophic hormone (LH) and thymosin on natural killer cell activity in BALB/c mice. Immunology 1988; 65: 125–128
   PubMed Web of Science ®Google Scholar
• Gossain V. V., Dimitrov N., Ashby D., Rovner D. R., Goldstein A. L. Effect of thymosin (fraction 5) on the plasma levels of glucose and glucoregulatory hormones in humans. J. Med 1988; 19: 335–343
   PubMedGoogle Scholar
• Costanzi J. J., Gagliano R. G., Delaney F., Harris N., Thurman G. B., Sakai H., Goldstein A. L., Loukas D., Cohen G. B., Thomson P. D. The effect of thymosin on patients with disseminated malignancies. Cancer 1977; 40: 14–19
   PubMed Web of Science ®Google Scholar
• Schafer L. A., Goldstein A. L., Gutterman J. U., Hersh E. M. In vitro and in vivo studies with thymosin in cancer patients. Ann. N.Y. Acad. Sci 1976; 277: 609–620
   PubMed Web of Science ®Google Scholar
• Patt Y. Z., Hersh E. M., Schafer L. A., Heilbrun L. K., Washington M. L., Gutterman J. U., Mavligit M., Goldstein A. L. Clinical and immunological evaluation of the use of thymosin plus BCG ± DTIC in the adjuvant treatment of stage 3B melanoma. Immune Modulation and Control of Neoplasia by Adjuvant Therapy, M. A. Chirigos. Raven Press, New York 1978; 357–371
   Google Scholar
• Zaizov R., Vogel R., Wolach B., Cohen I. J., Varsano I., Shohat B., Handzel Z., Rotter V., Yakir Y., Trainin N. The effect of THF in lymphoproliferative and myeloproliferative diseases in children. Ann. N.Y. Acad. Sci 1979; 332: 172–183
   PubMedGoogle Scholar
• Lipson S. D., Chretien P. B., Makuch R., Kenady D. E., Cohen M. H. Thymosin immunotherapy in patients with small cell carcinoma of the lung. Cancer 1979; 43: 863–870
   PubMed Web of Science ®Google Scholar
• Chretien P. B., Lipson S. D., Makuch R. W., Kenady D. E. Effects of thymosin in vitro in cancer patients and correlation with clinical course after thymosin immunotherapy. Ann. N.Y. Acad. Sci 1979; 332: 135–147
   PubMedGoogle Scholar
• Cohen M. H., Chretien P. B., Ihde D. C., Fossieck B. E., Makuch R., Bunn P. A., Jr., Johnston A. V., Shackney S. E., Matthews M. J., Lipson S. D., Kenady D. E., Minna J. D. Thymosin fraction V and intensive combination chemotherapy. JAMA 1979; 241: 1813–1815
   PubMed Web of Science ®Google Scholar
• Wara D. W., Goldstein A. L., Doyle N. E., Ammann A. J. Thymosin activity in patients with cellular immunodeficiency. N. Engl. J. Med 1975; 292: 70–74
   PubMed Web of Science ®Google Scholar
• Wara D. W., Ammann A. J. Thymic cells and humoral factors as therapeutic agents. Pediatrics 1976; 57: 643–645
   PubMed Web of Science ®Google Scholar
• Wara D. W., Ammann A. J. Thymosin treatment of children with primary immunodeficiency disease. Transplant Proc 1978; 10: 203–209
   PubMed Web of Science ®Google Scholar
• Barrett D. J., Wara D. W., Ammann A. J., Cowan M. J. Thymosin therapy in the DiGeorge syndrome. J. Pediat 1980; 97: 66–71
   PubMed Web of Science ®Google Scholar
• Low T. L. K., Hu S-K., Goldstein A. L. Complete amino acid sequence of bovine thymosin β4: A thymic hormone that induces terminal deoxynucleotidyl transferase activity in thymocyte populations. Proc. Natl. Acad. Sci. U.S.A 1981; 78: 1162–1166
   PubMed Web of Science ®Google Scholar
• Low T. L. K., Goldstein A. L. Chemical characterization of thymosin β4. J. Biol. Chem 1982; 257: 1000–1006
   PubMed Web of Science ®Google Scholar
• Low T. L. K., Mercer R. C. Isolation and structural studies of porcine, ovine and murine thymosin β4 by high-performance liquid chromatography. J. Chromatography 1984; 301: 221–239
   PubMed Web of Science ®Google Scholar
• Hannappel E. One-step procedure for the determination of thymosin β4 in small tissue samples and its separation from other thymosin β4-like peptides by high-pressure liquid chromatography. Anal. Biochem 1986; 156: 390–396
   PubMed Web of Science ®Google Scholar
• Wu A. F., Wood C., Wu T. T. Possibility of HIV gp 41 and thymosine beta-4 sharing the same antigenic epitope. AIDS 1989; 3: 319–325
   PubMed Web of Science ®Google Scholar
• Goodall G. J., Hempstead J. L., Morgan J. I. Production and characterization of antibodies to thymosin β4. J. Immunol 1983; 131: 821–825
   PubMed Web of Science ®Google Scholar
• Hannappel E., Xu G., Morgan J., Hempsted J., Horecker B. L. Thymosin β4: A ubiquitous peptide in rat and mouse tissues. Proc. Natl. Acad. Sci. U.S.A 1982; 79: 2172–2175
   PubMed Web of Science ®Google Scholar
• Erickson-Viitanen S., Ruggieri S., Natalini P., Horecker B. L. Distribution of thymosin β4 in vertebrate classes. Arch. Biochem. Biophys 1983; 221: 570–576
   PubMed Web of Science ®Google Scholar
• Xu G., Hannappel E., Morgan J., Hempstead J., Horecker B. L. Synthesis of thymosin β4 by peritoneal macrophages and adherent spleen cells. Proc. Natl. Acad. Sci. U.S.A 1982; 79: 4006–4009
   PubMed Web of Science ®Google Scholar
• Goodall G. J., Morgan J. I., Horecker B. L. Thymosin β4 in cultured mammalian cell lines. Arch. Biochem. Biophys 1983; 221: 598–601
   PubMed Web of Science ®Google Scholar
• Hannappel E., Leibold W. Biosynthesis rates and content of thymosin β4 in cell lines. Arch. Biochem. Biophys 1985; 240: 236–241
   PubMed Web of Science ®Google Scholar
• Watts J. D., Cary P. D., Sautiere P., Crane-Robinson C. Thymosins: Both nuclear and cytoplasmic proteins. Eur. J. Biochem 1990; 192: 643–651
   PubMedGoogle Scholar
• Naylor P. H., McClure J. E., Spangelo B. L., Low T. L. K., Goldstein A. L. Immunochemical studies on thymosin: Radioimmunoassay of thymosin β4. Immunopharmacology 1984; 7: 9–16
   PubMed Web of Science ®Google Scholar
• Suh B. Y., Naylor P. H., Goldstein A. L., Rebar R. W. Modulation of thymosin β4 by estrogen. Am. J. Obstet. Gynecol 1985; 151: 544–549
   PubMed Web of Science ®Google Scholar
• Hsia J., Sztein M. B., Naylor P. H., Simon G. L., Goldstein A. L., Hayden F. G. Modulation of thymosin α1 and thymosin β4 levels and peripheral blood mononuclear cell subsets during experimental rhinovirus colds. Lymphokine Res 1989; 8: 383–391
   PubMedGoogle Scholar
• Hannappel E., Van Kampen M. Determination of thymosin β4 in human blood cells and serum. J. Chromatography 1987; 397: 279–285
   PubMed Web of Science ®Google Scholar
• Hall N. R., McGillis J. P., Spangelo B. L., Goldstein A. L. Evidence for an interaction between thymosin peptides and the pituitary-gonadal axis. Fed. Proc 1982; 41: 1267–1272
   Google Scholar
• Tzehoval E., Sztein M. B., Goldstein A. L. Thymosin α1 and β4 potentiate the antigen presenting capacity of macrophages. Immunopharmacology 1989; 18: 107–113
   PubMed Web of Science ®Google Scholar
• Kokkinopoulos D., Perez S., Papamichail M. Thymosin β4 induced phenotypic changes in Molt-4 leukemic cell line. Blut 1985; 50: 341–348
   PubMedGoogle Scholar
• Baxevanis C. N., Recols G. J., Perez S., Kokkinopoulos D., Papamichail M. Immunoregulatory effects of fraction 5 thymus peptides. I. Thymosin α1 enhances while thymosin β4 suppresses the human autologous and allogeneic mixed lymphocyte reaction. Immunopharmacology 1987; 13: 133–141
   PubMed Web of Science ®Google Scholar
• Abiko T., Sekino H. Synthesis of six common amino acid sequence fragments of thymosin β4, β8 and β9 and determination of their effects on the low E-rosette forming cells of lupus nephritis patients. Chem. Pharm. Bull 1984; 32: 228–236
   PubMed Web of Science ®Google Scholar
• Abiko T., Sekino H. Deacetyl-thymosin β4: Synthesis and effect on the impaired peripheral T-cell subsets in patients with chronic renal failure. Chem. Pharm. Bull 1984; 32: 4497–4505
   PubMed Web of Science ®Google Scholar
• Abiko T., Sekino H. Synthesis of calf thymosin β4 fragment 16–38 and its effects on the impaired blastogenic response of T-lymphocytes of a uremic patient with pneumonia. Chem. Pharm. Bull 1987; 35: 3757–3765
   PubMed Web of Science ®Google Scholar
• Lenfant M., Wdzieczak-Bakala J., Guittet E., Prome J-C., Sotty D., Frindel E. Inhibitor of hematopoietic pluripotent stem cell proliferation: Purification and determination of its structure. Proc. Natl. Acad. Sci. U.S.A 1989; 86: 779–782
   PubMed Web of Science ®Google Scholar
• Monpezat J.-P., Frindel E. Further studies on the biological activities of the CFU-S inhibitory tetrapeptide AcSDKP. I. The precise point of the cell cycle sensitive to AcSDKP. Studies on the effect of AcSDKP on GM-CFC and on the possible involvement of T-lymphocytes in AcSDKP response. Exp. Hematol 1989; 17: 1077–1080
   PubMed Web of Science ®Google Scholar
• Lenfant M., Itoh K., Sakoda H., Sotty D., Sasaki N. A., Wdzieczak-Bakara J., Mori K. J. Enhancement of the adherence of hematopoietic stem cells to mouse bone marrow derived stromal cell line MS-1-T by a tetrapeptide Acetyl-N-Ser-Asp-Lys-Pro. Exp. Hematol 1989; 17: 898–902
   PubMed Web of Science ®Google Scholar
• Grillon C., Rieger K., Bakala J., Schott D., Morgat J.-L., Hannappel E., Voelter W., Lenfant M. Involvement of thymosin β4 and endopeptidase Asp-N in the biosynthesis of the tetrapeptide AcSerAspLysPro a regulator of the hematopoietic system. FEBS Letter 1990; 274: 30–34
   PubMed Web of Science ®Google Scholar
• Lombard M. N., Sotty D., Wdzieczak-Bakala J., Lenfant M. In vivo effect of the tetrapeptide, N-Acetyl-Ser-Asp-Lys-Pro, on the G1-S transition of rat hepatocytes. Cell Tissue Kinet 1990; 23: 99–103
   PubMedGoogle Scholar
• Wodnar-Filipowicz A., Gubler U., Furuichi Y., Richardson M., Nowoswiat E., Poonian M. S., Horecker B. L. Cloning and sequence analysis of cDNA for rat spleen thymosin β4. Proc. Natl. Acad. Sci. U.S.A 1984; 81: 2295–2297
   PubMed Web of Science ®Google Scholar
• Goodall G. J., Richardson M., Furuichi Y., Wodnar-Filipowicz A., Horecker B. L. Sequence of a cloned 523-bp cDNA for thymosin β4. Arch. Biochem. Biophys 1985; 236: 445–447
   PubMed Web of Science ®Google Scholar
• Wodnar-Filipowicz A., Horecker B. L. In vitro synthesis of thymosin β4 encoded by rat spleen mRNA. Proc. Natl. Acad. Sci. U.S.A 1983; 80: 1811–1815
   PubMed Web of Science ®Google Scholar
• Gondo H., Kudo J., White J. W., Barr C., Selvanayagam P., Saunders G. F. Differential expression of the human thymosin β4 gene in lymphocytes, macrophages, and granulocytes. J. Immunol 1987; 139: 3840–3848
   PubMed Web of Science ®Google Scholar
• Soma G., Murata M., Kitahara N., Gatanaga T., Shibai H., Morioka H., Andoh T. Detection of a counterscript in promyelocytic leukemia cells HL60 during early differentiation by TPA. Biochem. Biophys. Res. Commun 1985; 132: 100–109
   PubMed Web of Science ®Google Scholar
• Conlon J. M., Grimelius L., Wallin G., Thim L. Isolation and structural characterization of thymosin β4 from a human medullary thyroid carcinoma. J. Endocr 1988; 118: 155–159
   PubMed Web of Science ®Google Scholar
• Friedman R. L., Manly S. P., McMahon M., Kerr I. M., Stark G. R. Transcriptional and posttranscriptional regulation of interferon-induced gene expression in human cells. Cell 1984; 38: 745–755
   PubMed Web of Science ®Google Scholar
• Schöbitz B., Netzker R., Hannappel E., Brand K. Rapid induction of thymosin β4 in concanavalin-A stimulated thymocytes by translational control. J. Biol. Chem 1990; 265: 15387–15391
   PubMed Web of Science ®Google Scholar
• Atkinson M. J., Freeman M. W., Kronenberg H. M. Thymosin β4 is expressed in ROS 17/2.8 osteosarcoma cells in a regulated manner. Mol. Endocrinol 1990; 4: 69–74
   PubMed Web of Science ®Google Scholar
• Moscinski L. C., Prystowsky M. B. Identification of a series of differentiation-associated gene sequences from GM-CSF stimulated bone marrow. Oncogene 1990; 5: 31–37
   PubMed Web of Science ®Google Scholar
• Leonard D. G. B., Ziff E. B., Greene L. A. Identification and characterization of mRNAs regulated by nerve growth factor in PC12 cells. Mol. Cell. Biol 1987; 7: 3156–3167
   PubMed Web of Science ®Google Scholar
• McMahon M., Stark G., Kerr I. M. Interferon-α induced gene expression in wild-type and interferon resistant human lymphoblastoid (Daudi) cells. J. Virol 1986; 57: 362–366
   PubMed Web of Science ®Google Scholar
• Yancopoulos G. D., Oltz E. M., Rathbun G., Berman J. E., Smith R. K., Lansford R. D., Rothman P., Okada A., Lee G., Morrow M., Kaplan K., Prockop S., Alt F. W. Isolation of coordinately regulated genes that are expressed in discrete stages of B cell development. Proc. Natl. Acad. Sci. U.S.A 1990; 87: 5759–5763
   PubMed Web of Science ®Google Scholar
• Gómez-Márquez J., Dosil M., Segade F., Bustelo X. R., Pichel J. G., Dominguez F., Freire M. Thymosin β4 gene: Preliminary characterization and expression in tissues, thymic cells and lymphocytes. J. Immunol 1989; 143: 2740–2744
   PubMed Web of Science ®Google Scholar
• Lin S.-C., Morrison-Bogorad M. Developmental expression of mRNAs encoding thymosin β4 and β10 in rat brain and other tissues. J. Mol. Neurosci 1990; 2: 35–44
   PubMed Web of Science ®Google Scholar
• Shimamura R., Kudo J., Kondo H., Dohmen K., Gondo H., Okamura S., Ishibashi H., Niho Y. Expression of the thymosin β4 gene during differentiation of hematopoietic cells. Blood 1990; 76: 977–984
   PubMed Web of Science ®Google Scholar
• Rudin C. M., Engler P., Storb U. Differential splicing of thymosin β4 mRNA. J. Immunol 1990; 144: 4857–4862
   PubMed Web of Science ®Google Scholar
• Goodall G. J., Horecker B. L. (1987) Molecular biology of the thymosins. Immune regulation by characterized polypeptides. Proceeding of an Ortho-UCLA Symposium, Steamboat Springs, 1986, G. Goldstein. Alan R. Liss, Inc., New York, 283–292
   Google Scholar
• Clauss I. M., Wathelet M. G., Szpirer J., Islam M. Q., Levan G., Szpirer C., Huez G. A. Human thymosin β4/6–26 gene is part of a multigene family composed of seven members located on seven different chromosomes. Genomics 1991; 9: 174–180
   PubMed Web of Science ®Google Scholar
• Tsuji Y., Kitahara-Tanabe N., Noguchi K., Gatanaga T., Mizuno D., Soma G. Production in Escherichia coli of human thymosin β4 as chimeric protein with human tumor necrosis factor. Biochem. Int 1989; 18: 501–508
   PubMedGoogle Scholar